A Multiple Dose Escalation Study of ASKP1240 in Subjects With Moderate to Severe Plaque Psoriasis
This study has been completed.
Astellas Pharma Global Development, Inc.
First Posted: April 25, 2012
Last Update Posted: January 21, 2015
Kyowa Hakko Kirin Co., Ltd
Information provided by (Responsible Party):
Astellas Pharma Inc ( Astellas Pharma Global Development, Inc. )
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||January 2015|
|Primary Completion Date:||June 2014 (Final data collection date for primary outcome measure)|